Belozeroff V - Search Results

1

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet.

Belozeroff V, Lee A, Tseng S, Chiroli S, Campbell JD. Belozeroff V, et al. J Med Econ. 2013 Sep;16(9):1154-62. doi: 10.3111/13696998.2013.826665. Epub 2013 Aug 6. J Med Econ. 2013. PMID: 23869940 Free article. Clinical Trial.

2

Association of cinacalcet adherence and costs in patients on dialysis.

Lee A, Song X, Khan I, Belozeroff V, Goodman W, Fulcher N, Diakun D. Lee A, et al. Among authors: belozeroff v. J Med Econ. 2011;14(6):798-804. doi: 10.3111/13696998.2011.627404. Epub 2011 Oct 11. J Med Econ. 2011. PMID: 21988567 Free article.

3

Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.

Briggs AH, Parfrey PS, Khan N, Tseng S, Dehmel B, Kubo Y, Chertow GM, Belozeroff V. Briggs AH, et al. Among authors: belozeroff v. Med Decis Making. 2016 Nov;36(8):965-72. doi: 10.1177/0272989X16638312. Epub 2016 Mar 17. Med Decis Making. 2016. PMID: 26987347 Clinical Trial.

4

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.

Chiroli S, Mattin C, Belozeroff V, Perrault L, Mitchell D, Gioni I. Chiroli S, et al. Among authors: belozeroff v. BMC Nephrol. 2012 Oct 29;13:140. doi: 10.1186/1471-2369-13-140. BMC Nephrol. 2012. PMID: 23106934 Free PMC article.

5

Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States.

Boer R, Lalla AM, Belozeroff V. Boer R, et al. Among authors: belozeroff v. J Med Econ. 2012;15(3):509-20. doi: 10.3111/13696998.2012.664799. Epub 2012 Feb 21. J Med Econ. 2012. PMID: 22313328 Free article.

6

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Natoli JL, Boer R, Nathanson BH, Miller RM, Chiroli S, Goodman WG, Belozeroff V. Natoli JL, et al. Among authors: belozeroff v. BMC Nephrol. 2013 Apr 17;14:88. doi: 10.1186/1471-2369-14-88. BMC Nephrol. 2013. PMID: 23594621 Free PMC article. Review.

7

Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy.

Stollenwerk B, Iannazzo S, Cooper K, Belozeroff V. Stollenwerk B, et al. Among authors: belozeroff v. J Med Econ. 2017 Oct;20(10):1110-1115. doi: 10.1080/13696998.2017.1360309. Epub 2017 Aug 14. J Med Econ. 2017. PMID: 28803497 Free article.

8

Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value.

Campbell JD, Belozeroff V, Whittington MD, Rubin RJ, Raggi P, Briggs AH. Campbell JD, et al. Among authors: belozeroff v. Health Aff (Millwood). 2018 Aug;37(8):1298-1305. doi: 10.1377/hlthaff.2018.0221. Health Aff (Millwood). 2018. PMID: 30080450

9

Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients.

Belozeroff V, Goodman WG, Ren L, Kalantar-Zadeh K. Belozeroff V, et al. Clin J Am Soc Nephrol. 2009 Mar;4(3):673-9. doi: 10.2215/CJN.03790808. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261825 Free PMC article. Clinical Trial.

10

Hemodialysis patients' preferences for the management of secondary hyperparathyroidism.

Hauber B, Caloyeras J, Posner J, Brommage D, Belozeroff V, Cooper K. Hauber B, et al. Among authors: belozeroff v. BMC Nephrol. 2017 Jul 28;18(1):254. doi: 10.1186/s12882-017-0665-8. BMC Nephrol. 2017. PMID: 28750605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters